Rachor Investment Advisory Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Rachor Investment Advisory Services’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$2.62K	–	329
2026 Q1	$2.62K	Buy	5 +4	+400%	+$1.91K	﹤0.01%	225
2025 Q4	$583	Buy	+1	New	+$511	﹤0.01%	341

Other funds holding MDGL

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Rachor Investment Advisory Services's MDGL Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2026, closing a stake of 5 shares — an estimated $2.62K sold.

Rachor Investment Advisory Services first reported a position in MDGL in Q4 2025 and held it in 2 quarters. The position peaked at $2.62K in Q1 2026. 141 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Rachor Investment Advisory Services reported no remaining Madrigal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Rachor Investment Advisory Services sold 5 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.62K.
Rachor Investment Advisory Services first reported a position in Madrigal Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Rachor Investment Advisory Services's Madrigal Pharmaceuticals position peaked at $2.62K in Q1 2026.
141 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.